Winning comes to GXPi

Richard Winning becomes Clinical and Regulatory Project Manager at UK regulatory compliance specialist

UK regulatory compliance specialist GXPi has hired Richard Winning to help manage product delivery and migration and quality compliance services at the company, with particular emphasis in clinical areas.

Winning brings 35 years of experience and an extensive knowledge of the pharmaceutical and biopharma industry to the firm, tin addition to experience in delivering clinical trials programmes, clinical IT systems and procedural management systems.

GXPi provides expert consultancy to the global life sciences sector, delivering products and services that meet complex compliance requirements.

Winning's first assignment will focus on document migration and the development of expertise in that area to support the implementation of X-docs enterprise platform installations.

You may also like

Regulatory

GXPi acquires Netexperts

A life sciences IT hosting specialist
Regulatory

GXPi form makes regulatory compliance simpler

Adds X-forms extension to electronic document management platform
Regulatory

Broughton receives flexible scope ISO 17025 accreditation

New certification allows accreditation without prior approval
Regulatory

Overcoming CMC challenges in cell and gene therapy: part II

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
Regulatory

Overcoming CMC challenges in cell and gene therapy: part I

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
Regulatory

AskBio receives FDA Fast Track Designation for congestive heart failure gene therapy programme

The fast-tracking allows the development and expedition of review processes for AB-1002, a gene therapy to promote production of a constituently active form of I-1c
Manufacturing

Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success

Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena
Subscribe now